Sign In

Friday Session Handouts

Concurrent Morning Tracks 8:45 – 11:45 am

Track 1: What’s the Big Diff?—Patent Prosecution Under the AIA

Thurgood Marshall Ballroom, Mezzanine Level
  • Moderator: Paul Cole, Lucas & Co., Surrey, United Kingdom (Bio)

Most Important Changes Under the AIA—Laws, Rules, and Best Practices USPTO Perspective and Developments—Policy, Rules, and Examination Guidelines 8:50–9:10 am

  • Honorable Janet Gongola, US Patent & Trademark Office, Alexandria, VA (Bio, Slides)

In-House Perspectives on the AIA: Strategies for Successful Corporate Outcomes 9:10–9:30 am

International Perspectives and Developments: One Off, Harmonizing, Progress? 9:30–9:45 am

  • James Pooley, Deputy Director General, Innovation & Technology Sector, World Intellectual Property Organization, Geneva, Switzerland (invited)

Changes at the OED: What Corporations and Practitioners Need to Know and When You Need to Know It

9:45–10:15 am

  • William R. Covey, Office of Enrollment and Discipline, US Patent & Trademark Office, Alexandria, VA (invited) (Bio, Slides)

Practitioner Perspectives on Adapting Practice to the AIA Strategies, Tips, and Potholes 10:20–11:20 am

  • Courtenay Brinkerhoff, Foley & Lardner, LLP, Washington, DC (Paper)
  • Michael W. Piper, Conley Rose, Plano, TX (Bio, Paper)

Patent System RX: Pre-issuance Submissions 11:20–11:45 am

Track 2: Trademark Enforcement Around the Globe & Online

Marriott Ballroom Salon 1, Lobby Level

  • Moderator: Alyson G. Barker, The Wet Seal, Inc., Foothill Ranch, CA

The Benefits, Burdens, Alternatives and Ethics of Identifying and Enforcing Against Unknown Online Infringers 8:45–9:45 am

  • Stephen M. Gaffigan, Stephen M. Gaffigan, PA, Fort Lauderdale, FL (Bio, Paper)
  • Rudy Gaines, Marksmen, LLC, Chapel Hill, NC (Bio)

Extraterritorial Reach of the Lanham Act 9:45–10:15 am

  • Michael Gray, Gray Plant Mooty, Minneapolis, MN (Bio, Paper)

Enforceability of US Court Orders/Judgments and International Arbitration Orders/Judgments in Foreign Jurisdictions  10:15–11:45 am


  • George Chan, Rouse, LLP, Beijing, China (Bio, Paper)


  • Sven A. Klos, Klos Morel Vos & Schaap, Amsterdam, The Netherlands South/Central America (Bio, Paper)
  • Martin Chajchir, Marval O’Farrell & Mairal, Buenos Aires, Argentina (Bio, Paper)

Track 3: Theft of IP through Cyber Attacks— Legal Exposure and Legal Remedies

Maryland Ballroom, Lobby Level

(papers for this session)

  • Moderator: Daniel P. Westman, Morrison & Foerster, LLP, McLean, VA 

Cyber Attacks: The Nature of the Threat and Government/Private Partnerships

  • Andrew H. Tannenbaum, IBM Corporation, Armonk, NY (Bio, Paper)

Using the Computer Fraud and Abuse Act to Address Theft of Information Against Known and Unknown Defendants

  • Nick Akerman, Dorsey & Whitney, LLP, New York, NY  (Bio, Paper, Slides)

Litigation and Government Initiatives

  • Eric Klumb, US Department of Justice, Washington, DC (Bio, Paper)

Cybersecurity Legislation

  • Leonard E. Bailey, Associate Deputy Attorney General, US Department of Justice, Washington, DC (Paper)

Legal Exposure that Comes with a Cyber Attack/Data Breach

  • Elizabeth A. Rowe, University of Florida Levin College of Law, Gainesville, FL (Bio, Paper)

Law Firms and Risk Control—Information Security and Confidentiality

Lunch Reception (open to all registrants)

 11:45 am – 12:15 pm

Exhibition Hall A, Exhibition Level


Luncheon 12:15 – 1:45 pm

  • The Honorable Kathleen O’Malley, Circuit Judge, US Court of Appeals for the Federal Circuit, Washington, DC 

Concurrent Afternoon Tracks 2:00 – 3:30 pm

Track1: AIA—Will the New System Work?

Thurgood Marshall Ballroom, Mezzanine Level

  • Moderator: Q. Todd Dickinson, AIPLA, Arlington, VA

AIPLA Executive Director Q. Todd Dickinson will lead a frank and informative question and answer session with notable government, private practice, and industry IP stakeholders. The discussion will center around the expectations and early results from the various changes to the patent system implemented by the America Invents Act.


  • Honorable David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the US Patent & Trademark Office, Alexandria, VA (invited) (Bio, Slides)
  • Robert A. Armitage, Eli Lilly & Company, Indianapolis, IN (Bio, Paper, Paper2)
  • Aaron Cooper, Senior Counsel, IP and Antitrust, US Senate Committee on the Judiciary, Washington, DC (invited)
  • W. Todd Baker, Oblon Spivak McClelland Maier & Neustadt, LLP, Alexandria, VA (Bio, Paper)

Track 2: IP Licensing

Marriott Ballroom Salon 1, Lobby Level

  • Moderator: Gary Weinstein, Faegre Baker Daniels, LLP, Minneapolis, MN (Bio)

Designing a Patent Licensing Program

  • Robert C. Kahrl, University of Akron School of Law, Akron, OH (Bio, Paper)

Licensing of Trademarks and Copyright Works

  • Steve Levy, Accent Law Group, Philadelphia, PA (Bio, Paper)

IP Licensing in Nanotechnology

  • Raj S. Davé, Pillsbury Winthrop Shaw Pittman, LLP, Washington, DC (Bio, Paper)

IP Licensing in Information Technology

  • Karen F. Copenhaver, Choate Hall & Stewart, LLP, Boston, MA (Paper)

Track 3: Ethical Considerations in Litigation

Maryland Ballroom, Lobby Level

  • Moderator: Michael L. Doane, Adduci Mastriani & Schaumberg, LLP, Washington, DC (Bio)

Ethical Considerations in the ITC 2:00–2:30 pm

  • Honorable Charles E. Bullock, Chief Administrative Law Judge, US International Trade Commission, Washington, DC (Bio)

Inadvertent Production—New Rules, Protective Order Provisions, Length of Time Issues 2:30–3:00 pm

  • Douglas R. Nemec, Skadden Arps Slate Meagher & Flom, LLP, New York, NY (Bio, Paper)

Ethics and the Internet—Social Media and Cloud Computing 3:00–3:30 pm

  • Maura R. Grossman, Wachtell Lipton Rosen & Katz, New York, NY (Bio, Paper)

Committee Educational Sessions 3:30 – 5:30 pm

Commitee meetings and educational sessions are open to all attendees unless otherwise noted.

Biotechnology/IP Practice in Europe (Joint Session) (120 Minutes of CLE Requested)

Thurgood Marshall Ballroom, Mezzanine Level

  • Moderator: James Kelley, Eli Lilly & Company, Indianapolis, IN 

Antibody Patents and Patenting Antibodies—US and EP Perspectives Patenting Antibodies—A European Perspective The EP panel will explain and critique the EPO’s approach to inventive step and claim scope for antibodies.

Antibodies and the EPO

  • Andrew G. Smith, Eli Lilly & Company, Ltd., Windlesham, Surrey, United Kingdom (Bio, Slides)

International Antibody Patenting Strategy

  • Dr. Andreas Huebel, Michalski Hüttermann & Partner, Düsseldorf, Germany (Bio, Slides)

Patenting Antibodies in Europe

  • Louise Holliday, D. Young & Co., LLP, Southhampton, United Kingdom (Slides)

Antibody Patents—Written Description The US panel will focus on compliance with 45 U.S.C. §112(a) (written description).

Understanding the Patent Office’s "Antibody Exception"

  • Kristi Sawert, US Patent & Trademark Office, Alexandria, VA 

An Academic View

  • Chris Holman, University of Missouri–Kansas City School of Law, Kansas City, MO (Bio, Paper)

A Corporate View

  • Amy E. Hamilton, Eli Lilly & Company, Ltd., Indianapolis, IN (Bio, Paper)

An Industry View

  • Hans Sauer, Biotechnology Industry Organization, Washington, DC (Bio)

Licensing and Management of IP Assets (120 Minutes of CLE Requested)

Maryland Ballroom, Lobby Level

  • Moderator: Penny Prater, Chevron, San Ramon, CA 

The doctrine of licensing estoppel affects all technological disciplines of Patent Law. The Rates v. Speakeasy decision by the Second Circuit Court of Appeals held that patent licensing agreements reached before litigation cannot be used to bar a licensee from later challenging the validity of a patent. David Leichtman, counsel for Speakeasy, Inc. and Best Buy Co., Inc. will speak on the doctrine of licensing  estoppel and the affects of the decision.

  • Speaker:
    David Leichtman, Robins Kaplan Miller & Ciresi, LLP, New York, NY (Bio)
    D. Patrick O’Reilley, Finnegan Henderson Farabow Garrett & Dunner, LLP, Washington, DC (Bio)
  • Andrew Wu, IPValue Management Inc., Mountain View, CA (Bio)

    Committee Meetings 3:30 - 5:30 pm

Committee Meetings are open to all unless otherwise noted.​​​​​​​